MD-224
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


MD-224
Product Name Alternative:
trans-1-Aminocyclobutane-1,3-dicarboxylic acid, R80130, (S)-4-Carboxyphenylglycine, cis-1-Aminocyclobutane-1,3-dicarboxylic acidUNSPSC Description:
MD-224 is a first-in-class and highly potent small-molecule human murine double minute 2 (MDM2) degrader based on the proteolysistargeting chimera (PROTAC) concept. MD-224 consists of ligands for Cereblon and MDM2. MD-224 induces rapid degradation of MDM2 at concentrations IC50 value of 1.5 nM in inhibition of growth of RS4;11 cells. MD-224 has the potential to be a new class of anticancer agent[1]. MD-224 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.Target Antigen:
E1/E2/E3 Enzyme; MDM-2/p53; PROTACsType:
Reference compoundRelated Pathways:
Apoptosis;Metabolic Enzyme/Protease;PROTACField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/md-224.htmlPurity:
99.60Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
FC1=C(Cl)C=CC=C1[C@@H]2[C@@]3(C(C=CC(Cl)=C4)=C4NC3=O)C5(CCCCC5)N[C@H]2C(NC6=CC=C(C(NCCCC#CC7=C(CN(C8C(NC(CC8)=O)=O)C9=O)C9=CC=C7)=O)C=C6)=OMolecular Weight:
889.80References & Citations:
[1]Li Y, et al. Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis TargetingChimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable TumorRegression. J Med Chem. 2019 Jan 24;62(2):448-466Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Clinical Information:
No Development ReportedCAS Number:
2136247-12-4
